| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $91.5M | +67.8% |
| Cost of Revenue | $1.7M | -31.4% |
| R&D Expense | $248.7M | -5.0% |
| SG&A Expense | $79.5M | -15.0% |
| Operating Income | -$263.1M | +16.2% |
| Pre-tax Income | -$254.2M | +13.0% |
| Income Tax | $0 | — |
| Net Income | -$254.2M | +13.0% |
| EPS (Basic) | -$7.13 | +42.7% |
| EPS (Diluted) | -$7.13 | +42.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $71.0M | -45.5% |
| Short-term Investments | $195.2M | +45.0% |
| Accounts Receivable | $21.0M | +23.3% |
| Current Assets | $300.9M | +3.2% |
| Total Assets | $656.7M | -13.6% |
| Current Liabilities | $79.8M | -18.9% |
| Total Liabilities | $346.2M | -13.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$237.1M | -14.5% |
| Capital Expenditures | $22.8M | +97.3% |
| Investing Cash Flow | $11.7M | -24.1% |
| Financing Cash Flow | $166.2M | -53.2% |
| Free Cash Flow | -$260.0M | -18.9% |
| Stockholders' Equity |
| $310.5M |
| -13.7% |